Amag Pharmaceuticals (AMAG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1997 | 12-1996 | 12-1995 | 12-1994 | 12-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,725 | 12,840 | 2,526 | 4,385 | 24,344 |
| Marketable Securities | 27,366 | 27,146 | 37,691 | 33,266 | 15,872 |
| Receivables | 547 | 830 | 1,254 | 739 | 275 |
| Inventories | 113 | 50 | 81 | 0 | 0 |
| Other current assets | 224 | 268 | 159 | 216 | 585 |
| TOTAL | $38,975 | $41,134 | $41,711 | $38,606 | $41,076 |
| Non-Current Assets | |||||
| PPE Net | 5,752 | 6,124 | 6,859 | 6,726 | 6,529 |
| Other Non-Current Assets | 0 | 196 | 145 | 97 | 56 |
| TOTAL | $5,752 | $6,320 | $7,004 | $6,823 | $6,585 |
| Total Assets | $44,976 | $47,454 | $48,715 | $45,429 | $47,660 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 441 | 557 | 445 | 436 |
| Accrued Expenses | N/A | 997 | 638 | 545 | 513 |
| TOTAL | $1,553 | $1,488 | $1,325 | $990 | $1,035 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,553 | $1,488 | $1,325 | $990 | $1,035 |
| Shareholders' Equity | |||||
| Common Shares | 67 | 67 | 68 | 67 | 67 |
| Retained earnings | N/A | -2,401 | 1,112 | 34 | 1,784 |
| Other shareholders' equity | 43,356 | 3,684 | 1,046 | -513 | 0 |
| TOTAL | $43,423 | $45,966 | $47,390 | $44,439 | $46,625 |
| Total Liabilities And Equity | $44,976 | $47,454 | $48,715 | $45,429 | $47,660 |